OCUL

OCULAR THERAPEUTIX, INC

—

$9.66

+6.94% today

last filing 2026-02-23Pro sees filings in ~15 min

Price

hover · 4 moves explained

1 buy29 sells6 8-K

Analyst consensus

Strong Buy

$27.09target+180.4%vs $9.66 today

$18.00 low today target$34.00 high

11 analysts · ~12-month consensus · as of Jul 7. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 1 of last 4

Earnings per share · actual vs forecast

Q2 '25-10.7%

−$0.39

exp −$0.35

Q3 '25-9.6%

−$0.38

exp −$0.35

Q4 '25+13.9%

−$0.29

exp −$0.34

Q1 '26-27.6%

−$0.40

exp −$0.32

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Sell	2026-02-25	Nayak Sanjay	Chief Strategy Officer	—Direct	1,759	$8.28	$14.6K
Sell	2026-02-25	Kaiser Peter	Chief Development Officer	—Direct	2,810	$8.28	$23.3K
Sell	2026-02-25	Heier Jeffrey S.	Chief Scientific Officer	—Direct	3,057	$8.28	$25.3K
Sell	2026-02-25	Dugel Pravin	See Remarks	—Direct	20,056	$8.28	$166.1K
Sell	2026-02-24	Waheed Nadia	Chief Medical Officer	—Direct	3,510	$7.74	$27.2K

Sell

Nayak Sanjay

Chief Strategy Officer · 2026-02-25

$14.6K

1,759 @ $8.28

Sell

Kaiser Peter

Chief Development Officer · 2026-02-25

$23.3K

2,810 @ $8.28

Sell

Heier Jeffrey S.

Chief Scientific Officer · 2026-02-25

$25.3K

3,057 @ $8.28

Sell

Dugel Pravin

See Remarks · 2026-02-25

$166.1K

20,056 @ $8.28

Sell

Waheed Nadia

Chief Medical Officer · 2026-02-24

$27.2K

3,510 @ $7.74

48 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →